ERBB2 and breast cancer: For example, since the sample is judged to be triple negative on the basis of conventional IHC (from annotations provided with the commercially obtained samples), the Her2, PR and ER probes are not expected to produce signals [see (Yagnik et al., 2021) for an example of these probes on Her2 and hormone receptor positive breast cancer samples].